Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats

Psychopharmacology

Volumn 223, Issue 1, 2012, Pages 17-25

  Goeders, Nicholas E ^a,b   Cohen, Ami ^d   Fox, Barbara S ^b   Azar, Marc R ^c   George, Olivier ^d   Koob, George F ^d  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Embera NeuroTherapeutics Inc   (United States)

^c Behavioral Pharma Inc   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Benzodiazepine; Corticotropin releasing factor; HPA axis; Metyrapone; Nicotine; Oxazepam; Rat; Reinforcement; Self administration; Varenicline

Indexed keywords

METYRAPONE; NICOTINE; OXAZEPAM; VARENICLINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SELF ADMINISTRATION; INHIBITION (PSYCHOLOGY); LOW DRUG DOSE; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SMOKING CESSATION;

ANIMALS; BENZAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MALE; METYRAPONE; NICOTINE; OXAZEPAM; QUINOXALINES; RATS; RATS, WISTAR; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SMOKING CESSATION;

EID: 84865129407     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2682-4     Document Type: Article

References (63)

1. Albertsen K, Borg V, Oldenburg B (2006) A systematic review of the impact of work environment on smoking cessation, relapse and amount smoked. Prev Med 43:291-305. doi: 10.1016/j.ypmed.2006.05.001 (Pubitemid 44528704)
2. HJ Aubin A Bobak JR Britton C Oncken CB Billing Jr J Gong KE Williams KR Reeves 2008 Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial Thorax 63 717 724 10.1136/thx.2007.090647
3. Caggiula AR, Donny EC, Epstein LH, Sved AF, Knopf S, Rose C, McAllister CG, Antelman SM, Perkins KA (1998) The role of corticosteroids in nicotine's physiological and behavioral effects. Psychoneuroendocrinology 23:143-159. doi: 10.1016/S0306-4530(97)00078-4 (Pubitemid 28248468)
4. Cahill K, Stead L, Lancaster T (2009) A preliminary benefit-risk assessment of varenicline in smoking cessation. Drug Saf 32:119-135. doi: 10.2165/00002018-200932020-00005
5. Chen H, Fu Y, Sharp BM (2008) Chronic nicotine self-administration augments hypothalamic-pituitary-adrenal responses to mild acute stress. Neuropsychopharmacology 33:721-730. doi: 10.1038/sj.npp. 1301466 (Pubitemid 351252701)
6. Chouinard G (2004) Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 65(Suppl 5):7-12
7. Doll R, Peto R, Boreham J, Sutherland I (2004) Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328:1519. doi: 10.1136/bmj.38142.554479
8. Engelhardt D, Dorr G, Jaspers C, Knorr D (1985) Ketoconazole blocks cortisol secretion in man by inhibition of adrenal 11 beta-hydroxylase. Klin Wochenschr 63:607-612 (Pubitemid 15039601)
9. George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, Parsons LH, O'Dell LE, Richardson HN, Koob GF (2007) CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci USA 104:17198-17203. doi: 10.1073/pnas.070758510 (Pubitemid 350211014)
10. George O, Lloyd A, Carroll FI, Damaj MI, Koob GF (2011) Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology (Berl) 213:715-722. doi: 10.1007/s00213-010-2024-34
11. Goeders NE (2002) Stress and cocaine addiction. J Pharmacol Exp Ther 301:785-789. doi:10.1124/jpet.301.3.785 (Pubitemid 34595065)
12. Goeders NE (2004) Stress, motivation, and drug addiction. Current directions in psychological science 13:33-35.
13. Goeders NE (2007) Hypothalamic-pituitary-adrenocortical axis and addiction. In: al'Absi M (ed) Stress and addiction. Elsevier Neuroscience, London, pp 21-40
14. Goeders NE, Guerin GF (1996) Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 722:145-152.doi:10.1016/0006-8993(96) 00206-5 (Pubitemid 26199364)
15. Goeders NE, Guerin GF (2008) Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats. Pharmacol Biochem Behav 91:181-189. doi: 10.1016/j.pbb.2008.07.005
16. Goeders NE, McNulty MA, Mirkis S, McAllister KH (1989) Chlordiazepoxide alters intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 33:859-866. doi: 10.1016/0091-3057(89)90483-8 (Pubitemid 19284301)
17. Goeders NE, McNulty MA, Guerin GF (1993) Effects of alprazolam on intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 44:471-474. doi: 10.1016/0091-3057(93)90493-D
18. Goeders NE, Peltier RL, Guerin GF (1998) Ketoconazole reduces low dose cocaine self-administration in rats. Drug Alcohol Depend 53:67-77. doi: 10.1016/S0376-8716(98)00108-2 (Pubitemid 28558799)
19. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR (2006) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 296:47-55. doi: 10.1001/jama.296.1.47
20. Grottoli S, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, DeStefanis S, Camanni F, Ghigo E, Arvat E (2002) Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans. J Endocrinol Invest 25:420-425 (Pubitemid 34516587)
21. Haleem DJ, Kennett G, Curzon G (1988) Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis. Brain Res 458:339-347. doi: 10.1016/0006-8993(88)90476-3
22. Harrison-Woolrych M (2009) Varenicline and suicide. Safety data from New Zealand BMJ 339:b5654. doi: 10.1136/bmj.b5654
23. Haynes RC Jr (1990) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon, New York, pp 1431-1462
24. Heishman SJ (1999) Behavioral and cognitive effects of smoking: relationship to nicotine addiction. Nicotine Tob Res 1(Suppl 2):S143-S147. doi: 10.1080/14622299050011971, discussion S165-146
25. Hubner CB, Koob GF (1990) The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat. Brain Res 508:20-29. doi: 10.1016/0006-8993(90)91112-T (Pubitemid 20042060)
26. Hyytia P, Schulteis G, Koob GF (1996) Intravenous heroin and ethanol self-administration by alcohol-preferring AA and alcohol-avoiding ANA rats. Psychopharmacology (Berl) 125:248-254. doi: 10.1007/BF02247335 (Pubitemid 26184810)
27. Jonkman S, Risbrough VB, Geyer MA, Markou A (2008) Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology 33:2131-2138. doi: 10.1038/sj.npp. 1301607 (Pubitemid 351992083)
28. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR (2006) Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296:56-63. doi: 10.1001/jama.296.1.56
29. Kassel JD, Stroud LR, Paronis CA (2003) Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull 129:270-304. doi: 10.1037/0033-2909.129.2.270 (Pubitemid 38389556)
30. Keating GM, Lyseng-Williamson KA (2010) Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. PharmacoEconomics 28:231-254. doi: 10.2165/11204380-000000000-00000
31. Keim KL, Sigg EB (1977) Plasma corticosterone and brain catecholamines in stress: effect of psychotropic drugs. Pharmacol Biochem Behav 6:79-85. doi: 10.1016/0091-3057(77)90162-9 (Pubitemid 8079131)
32. Koob GF, Goeders NE (1989) Neuroanatomical substrates of drug self-administration. Oxford University Press, London
33. Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149-1159. doi: 10.1176/appi.ajp.2007.05030503 (Pubitemid 47292402)
34. Le Foll B, Goldberg SR (2006) Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology (Berl) 184:367-381. doi: 10.1007/s00213-005-0155-8 (Pubitemid 43255853)
35. Lilja J, Larsson S, Skinhoj KT, Hamilton D (2001) Evaluation of programs for the treatment of benzodiazepine dependency. Subst Use Misuse 36:1213-1231. doi: 10.1081/JA-100106224 (Pubitemid 32937047)
36. Lowery EG, Thiele TE (2010) Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol Disord Drug Targets 9:77-86
37. Majewska MD (2002) HPA axis and stimulant dependence: an enigmatic relationship. Psychoneuroendocrinology 27:5-12. doi: 10.1016/S0306-4530(01) 00033-6 (Pubitemid 34028155)
38. Marcinkiewcz CA, Prado MM, Isaac SK, Marshall A, Rylkova D, Bruijnzeel AW (2009) Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology 34:1743-1752. doi: 10.1038/npp.2008.231
39. McNeil JJ, Piccenna L, Ioannides-Demos LL (2010) Smoking cessation-recent advances. Cardiovasc Drugs Ther 24:359-367. doi: 10.1007/s10557-010-6246-8
40. Meador-Woodruff JH, Greden JF (1988) Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation. Endocrinol Metab Clin North Am 17:225-234
41. Mendelson JH, Sholar MB, Goletiani N, Siegel AJ, Mello NK (2005) Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men. Neuropsychopharmacology 30:1751-1763. doi: 10.1038/sj.npp.1300753 (Pubitemid 43086032)
42. Mendelson JH, Goletiani N, Sholar MB, Siegel AJ, Mello NK (2008) Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic- pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology 33:749-760. doi: 10.1038/sj.npp.1301455 (Pubitemid 351252690)
43. Moore TJ, Furberg CD (2009) Varenicline and suicide. Risk of psychiatric side effects with varenicline. BMJ 339:b4964. doi: 10.1136/bmj.b4964
44. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P (2009) Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 338:b1024. doi: 10.1136/bmj.b1024
45. O'Brien CP (2005) Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66(Suppl 2):28-33 (Pubitemid 40343678)
46. O'Connor EC, Parker D, Rollema H, Mead AN (2010) The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology (Berl) 208:365-376. doi: 10.1007/s00213-009-1739-
47. O'Dell LE, Khroyan TV (2009) Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans? Pharmacol Biochem Behav 91:481-488. doi: 10.1016/j.pbb.2008.12.011
48. Paterson NE (2009) Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights. Eur J Pharmacol 603:1-11. doi: 10.1016/j.ejphar.2008.12.009
49. Pecina S, Schulkin J, Berridge KC (2006) Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward: paradoxical positive incentive effects in stress? BMC Biol 4:8. doi: 10.1186/1741-7007-4-8
50. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321:323-329. doi: 10.1136/bmj.321.7257.323 (Pubitemid 30496873)
51. Pickworth WB, Fant RV (1998) Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans. Psychoneuroendocrinology 23:131-141. doi: 10.1016/S0306-4530(97)00075-9 (Pubitemid 28248467)
52. Pomerleau OF, Pomerleau CS (1991) Research on stress and smoking: progress and problems. Br J Addict 86:599-603. doi: 10.1111/j.1360-0443.1991. tb01815.x
53. Ray R, Schnoll RA, Lerman C (2007) Pharmacogenetics and smoking cessation with nicotine replacement therapy. CNS Drugs 21:525-533 (Pubitemid 46984855)
54. Rohleder N, Kirschbaum C (2006) The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. Int J Psychophysiol 59:236-243. doi: 10.1016/j.ijpsycho.2005.10.012
55. Rose JE, Behm FM, Salley AN, Bates JE, Coleman RE, Hawk TC, Turkington TG (2007) Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology 32:2441-2452. doi: 10.1038/sj.npp. 1301379 (Pubitemid 350126832)
56. Silberman Y, Bajo M, Chappell AM, Christian DT, Cruz M, Diaz MR, Kash T, Lack AK, Messing RO, Siggins GR, Winder D, Roberto M, McCool BA, Weiner JL (2009) Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions. Alcohol 43:509-519. doi: 10.1016/j.alcohol.2009.01.002
57. Smagin GN, Goeders NE (2004) Effects of acute and chronic ketoconazole administration on hypothalamo-pituitary-adrenal axis activity and brain corticotropin-releasing hormone. Psychoneuroendocrinology 29:1223-1228. doi: 10.1016/j.psyneuen.2004.02.004 (Pubitemid 39024347)
58. Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV (1993) Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man. J Clin Endocrinol Metab 76:388-391. doi: 10.1210/jc.76.2.388 (Pubitemid 23073061)
59. Van Vugt DA, Piercy J, Farley AE, Reid RL, Rivest S (1997) Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition. Endocrinology 138:2249-2258. doi: 10.1210/en.138.6.2249 (Pubitemid 27215222)
60. West R (2009) The multiple facets of cigarette addiction and what they mean for encouraging and helping smokers to stop. COPD 6:277-283
61. Wilkes S (2008) The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis 3:45-53. doi: 10.2147/COPD.S1121 (Pubitemid 351523717)
62. Wilson MA, Biscardi R, Smith MD, Wilson SP (1996) Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats. J Pharmacol Exp Ther 278:1073-1082 (Pubitemid 27166955)
63. Yang XM, Gorman AL, Dunn AJ, Goeders NE (1992) Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Pharmacol Biochem Behav 41:643-650. doi: 10.1016/0091-3057(92)90386-T